Home/Recordati/Robert Koremans
RK

Robert Koremans

Chief Executive Officer

Recordati

Recordati Pipeline

DrugIndicationPhase
Rare Disease PortfolioCushing's Disease, Acromegaly, Acute Hepatic PorphyriasMarketed
Specialty & Primary Care PortfolioCardiovascular, Urology, Mental HealthMarketed